AGC Completes Third-Party Verification Under UL 2809 for Fluorine Raw Materials Used in AFLAS™ FFKM
29.5.2026 04:00:00 CEST | Business Wire | Press release
－Fluorine Content attributed as 100% “Recycled Circular Fluorite” Based on Mass Balance Credit Allocation－
AGC (TOKYO:5201) (AGC Inc., Headquarters: Tokyo; President: Yoshinori Hirai) a world-leading manufacturer of glass, chemicals and other high-tech materials, announces that it has completed a third-party verification*1 based on UL 2809*2 in May 2026 for the fluorine raw materials used in AFLAS™ FFKM. The third-party verification confirmed that, for allocation of recycled content under the mass balance approach*3, 100%*4 of the fluorine content allocated to AFLAS™ FFKM is attributed to recycled fluorite (hereinafter “Recycled Circular Fluorite”). This initiative is among the industry-leading levels*5 of recycled material utilization in fluoroelastomer materials.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260528992272/en/
Environmental Claim Validation labels for the three AFLAS™ FFKM product lines
AFLAS™ FFKM is an industrial elastomer that offers one of the highest levels of chemical resistance, heat resistance, and plasma resistance among fluorinated elastomers, and is used in a wide range of applications, particularly in the semiconductor manufacturing sector. Its resistance to degradation under harsh conditions makes it suitable for use in sealing materials and O-rings in applications requiring high reliability and durability.
The AGC Group has been working to recycle waste generated at its own plants and utilize it in fluorine products as Recycled Circular Fluorite. In 2025, the AGC Group was the first in the world to complete third-party verification based on UL 2809 for Fluon™ PTFE. With the completion of this verification, the AGC Group has prepared to offer AFLAS™ FFKM as a product that successfully combines high performance with environmental considerations.
After completing this verification, the AGC Group is ready to introduce AFLAS™ FFKM, a product that blends exceptional performance with environmental awareness.
Under its mid-term management plan AGC plus-2026, the AGC Group identifies “Deepening of Sustainability Management” as one of its key strategies. The Group will continue to actively work toward the realization of a circular economy for fluorine resources.
Notes | |
*1 | This involves a third-party organization verifying the actual use of Recycled Circular Fluorite and evaluating whether the management of raw material credits complies with the relevant regulations based on the mass balance approach specified in UL 2809. |
*2 | UL 2809 (ECV: Environmental Claim Validation): A standard for verifying the content of recycled materials in a product by evaluating it in accordance with the environmental performance verification procedure for recycled material content established by UL Solutions, Inc. in the United States. |
*3 | A method used when manufacturing by blending raw materials with different properties (e.g., Recycled Circular Fluorite and mined fluorite), whereby the properties of the recycled raw materials are “allocated” to a portion of the final product in proportion to the percentage of recycled material used. For example, if 20% Recycled Circular Fluorite is used in the overall manufacturing process, up to 20% of the final product may be designated as “100% Recycled Circular Fluorite”, while the remaining 80% is treated as “0%.” |
*4 | In the chemical composition of AFLAS™ FFKM polymer grades, fluorine atoms account for approximately 73 wt% of the total composition. Based on the mass balance approach, AGC manages the raw materials for this fluorine component such that 100 wt% is derived from recycled materials. The remainder of the composition consists primarily of carbon. |
*5 | Based on AGC’s research (as of May 2026) |
Reference
- You can verify this by searching for “AFLAS” in UL Solutions’ UL-SPOT (https://spot.ul.com/)
- AFLAS™ FFKM Product Information
- For additional information regarding AGC Group’s initiative toward realizing a circular economy for fluorine resources, please refer to our website.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260528992272/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom